Literature DB >> 23121204

British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012.

V A Venning1, K Taghipour, M F Mohd Mustapa, A S Highet, G Kirtschig.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23121204     DOI： 10.1111/bjd.12072

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  27 in total

1.  Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.

Authors:  Joost M Meijer; Gilles F H Diercks; Emma W G de Lang; Hendri H Pas; Marcel F Jonkman
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

2.  Localised bullous pemphigoid overlying knee arthroplasty: a diagnostic challenge.

Authors:  Adam Truss; Stylianos Papalexandris; Susan Gardner; Robert Harvey
Journal:  BMJ Case Rep       Date:  2019-04-05

3.  [Bullous pemphigoid].

Authors:  F Schulze; M Kasperkiewicz; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2013-12       Impact factor: 0.751

4.  Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature.

Authors:  Meital Oren-Shabtai; Noa Kremer; Moshe Lapidoth; Eran Sharon; Lihi Atzmony; Adi Nosrati; Emmilia Hodak; Daniel Mimouni; Assi Levi
Journal:  Drugs Aging       Date:  2020-11-24       Impact factor: 3.923

5.  [Bullous pemphigoid: a new look at a well-known disease].

Authors:  G Balakirski; H F Merk; M Megahed
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

6.  Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.

Authors:  Yun-Ju Tsai; Yung-Tsu Cho; Chia-Yu Chu
Journal:  Am J Clin Dermatol       Date:  2022-05-17       Impact factor: 6.233

7.  Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

Authors:  J M Mason; J R Chalmers; T Godec; A J Nunn; G Kirtschig; F Wojnarowska; M Childs; D Whitham; E Schmidt; K Harman; S Walton; A Chapman; H C Williams
Journal:  Br J Dermatol       Date:  2018-01-15       Impact factor: 9.302

8.  Omalizumab therapy for bullous pemphigoid.

Authors:  Kenneth K Yu; Ashley B Crew; Kelly A N Messingham; Janet A Fairley; David T Woodley
Journal:  J Am Acad Dermatol       Date:  2014-06-20       Impact factor: 15.487

9.  A case of oropharyngeal bullous pemphigoid presenting with haemoptysis.

Authors:  C M Lee; H K Leadbetter; J M Fishman
Journal:  Case Rep Otolaryngol       Date:  2015-01-06

Review 10.  Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.

Authors:  Xinyi Chen; Wenlin Zhao; Hongzhong Jin; Li Li
Journal:  Front Med (Lausanne)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.